Company Profile

Today CANF ranks # as BUY CANDIDATE.
Today CANF ranks # as BUY CANDIDATE.

CANF stock Can-Fite BioPharma Ltd

CANF stock
Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd

10 Bareket Street

Petah-Tikva, 4951778

972 3 924 1114

www.canfite.co.il

Industry: Biotechnology

Sector: Healthcare


Description

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases, as well as sexual dysfunction. It offers CF101, which has completed Phase II/III clinical trials for the treatment of psoriasis; completed Phase II clinical trials for the treatment of rheumatoid arthritis; completed Phase I clinical study for the treatment of osteoarthritis; and completed Phase I study for the treatment of uveitis, as well as is in Phase II clinical trials for the treatment of glaucoma or related syndromes of ocular hypertension. The company also develops CF102 that conducts a Phase II study for treating hepatocellular carcinoma and hepatitis C virus; and CF602, which is in pre-clinical trial for the treatment of sexual dysfunction. Can-Fite BioPharma Ltd. is headquartered in Petah-Tikva, Israel.

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank